Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine

This publication has 40 references indexed in Scilit:

• Modeling Human Papillomavirus Vaccine Effectiveness: Quantifying the Impact of Parameter Uncertainty
  American Journal of Epidemiology, 2007
• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
  British Journal of Cancer, 2006
• Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes
  Vaccine, 2006
• Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs
  JAMA, 2003
• On the analysis of viral load endpoints in HIV vaccine trials
  Statistics in Medicine, 2003
• Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
  JNCI Monographs, 2003
• Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
  British Journal of Cancer, 2003
• Cost Effectiveness of a Potential Vaccine forHuman papillomavirus
  Emerging Infectious Diseases, 2003
• A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
  New England Journal of Medicine, 2002
• The 2001 Bethesda SystemTerminology for Reporting Results of Cervical Cytology
  JAMA, 2002